title: HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes.
abstract: In previous work we showed that endothelin-1 (ET-1) increases the rate of glucose uptake in astrocytes, an important aspect of brain function since glucose taken up by astrocytes is used to supply the neurons with metabolic substrates. In the present work we sought to identify the signalling pathway responsible for this process in primary culture of rat astrocytes. Our results show that ET-1 promoted an increase in the transcription factor hypoxia-inducible factor-1α (HIF-1α) in astrocytes, as shown in other cell types. Furthermore, HIF-1α-siRNA experiments revealed that HIF-1α participates in the effects of ET-1 on glucose uptake and on the expression of GLUT-1, GLUT-3, type I and type II hexokinase. We previously reported that these effects of ET-1 are mediated by connexin43 (Cx43), the major gap junction protein in astrocytes. Indeed, our results show that silencing Cx43 increased HIF-1α and reduced the effect of ET-1 on HIF-1α, indicating that the effect of ET-1 on HIF-1α is mediated by Cx43. The activity of oncogenes such as c-Src can up-regulate HIF-1α. Since Cx43 interacts with c-Src, we investigated the participation of c-Src in this pathway. Interestingly, both the treatment with ET-1 and with Cx43-siRNA increased c-Src activity. In addition, when c-Src activity was inhibited neither ET-1 nor silencing Cx43 were able to up-regulate HIF-1α. In conclusion, our results suggest that ET-1 by down-regulating Cx43 activates c-Src, which in turn increases HIF-1α leading to the up-regulation of the machinery required to take up glucose in astrocytes. Cx43 expression can be reduced in response not only to ET-1 but also to various physiological and pathological stimuli. This study contributes to the identification of the signalling pathway evoked after Cx43 down-regulation that results in increased glucose uptake in astrocytes. Interestingly, this is the first evidence linking Cx43 to HIF-1, which is a master regulator of glucose metabolism.
authors.affiliation: Departamento de Bioquímica y Biología Molecular, Instituto de Neurociencias de Castilla y León (INCYL), Universidad de Salamanca, Salamanca, Spain.
authors.forename: José Carlos
authors.initials: JC
authors.lastname: Valle-Casuso
authors.forename: Ana
authors.initials: A
authors.lastname: González-Sánchez
authors.forename: José M
authors.initials: JM
authors.lastname: Medina
authors.forename: Arantxa
authors.initials: A
authors.lastname: Tabernero
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000166:cytology; D000081247:CSK Tyrosine-Protein Kinase; D049109:Cell Proliferation; D018031:Connexin 43 / Q000096:biosynthesis*; D003847:Deoxyglucose / Q000378:metabolism; D019332:Endothelin-1 / Q000378:metabolism*; D017629:Gap Junctions / Q000378:metabolism; D020868:Gene Silencing; D005947:Glucose / Q000493:pharmacokinetics*; D051793:Hypoxia-Inducible Factor 1 / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015854:Up-Regulation; D019061:src-Family Kinases
chemical_list: D018031:Connexin 43; D019332:Endothelin-1; D051793:Hypoxia-Inducible Factor 1; D034741:RNA, Small Interfering; D003847:Deoxyglucose; D011505:Protein-Tyrosine Kinases; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases; D005947:Glucose